Pàgina inicial > Resultats de la cerca: Kokolakis, Georgios
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
16 p, 827.8 KB Brodalumab Is Associated with High Rates of Complete Clearance and Quality of Life Improvement : A Subgroup Analysis of Patients with Psoriasis and Concomitant Psoriatic Arthritis / Kokolakis, Georgios (Charité - Universitätsmedizin Berlin) ; Vadstrup, Kasper (LEO Pharma A/S (Dinamarca)) ; Hansen, Jes B. (LEO Pharma A/S (Dinamarca)) ; Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Psoriatic arthritis (PsA) is a chronic inflammatory disease associated with psoriasis that significantly impairs physical function and quality of life (QoL). Prompt therapeutic intervention is crucial for limiting PsA progression and preventing disability. [...]
2021 - 10.1159/000520290
Dermatology (Basel, Switzerland), Vol. 238 (november 2021) , p. 620-629  
Registre complet - Creative Commons
2.
16 p, 2.0 MB Increased Skin Clearance and Quality of Life Improvement with Brodalumab Compared with Ustekinumab in Psoriasis Patients with Aggravating Lifestyle Factors / Kokolakis, Georgios (Charité-Universitätsmedizin Berlin. Clinic of Dermatology, Venereology and Allergology, Psoriasis Research and Treatment Centre) ; Vadstrup, Kasper (LEO Pharma A/S) ; Hansen, Jes Birger (LEO Pharma A/S) ; Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Obesity, smoking, and alcohol consumption are prevalent in psoriasis patients and have been associated with increased disease severity and reduced treatment adherence and response. This post hoc analysis of pooled data from the phase 3 AMAGINE-2 and -3 trials compared the efficacy of brodalumab versus ustekinumab in psoriasis patients with aggravating and potentially treatment-confounding lifestyle risk factors. [...]
2021 - 10.1007/s13555-021-00618-5
Dermatology and Therapy, Vol. 11 (october 2021) , p. 2027-2042  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem